MTOR and gastric cancer: In a previous study using patient-derived GC organoids, PD-L1 expression decreased in knockdown of HER2 resulting in the inhibition of the AKT-mTOR pathway in PD-L1/HER2-positive GC cells and was correlated with an increase in cytotoxic T lymphocyte proliferation [44].